FDA Re-Org Makes Chief Of Staff Liaison Between Centers, Commissioner
This article was originally published in The Tan Sheet
Executive Summary
The newly created FDA Office of the Chief of Staff will serve as the major point of contact for communication from FDA centers and offices to the commissioner, according to an Aug. 30 Federal Register notice
You may also be interested in...
FDA’s New Chief Of Staff Suggested Greater Authority On Nano-Supplements
FDA’s new chief of staff has recommended pre-market registration and testing of products with nanoparticles and post-market reviews of nano-engineered supplement ingredients.
FDA’s New Chief Of Staff Suggested Greater Authority On Nano-Supplements
FDA’s new chief of staff has recommended pre-market registration and testing of products with nanoparticles and post-market reviews of nano-engineered supplement ingredients.
Winckler leaves FDA
Susan Winckler, FDA chief of staff since January 2007, resigns, giving Commissioner Peggy Hamburg and the Obama administration further room to shape the agency. Winckler joined FDA as director for policy communications in September 2006, after serving as VP of policy and communications and staff counsel for the American Pharmacists Association. An August 2007 reorganization gave FDA's chief of staff a more central role and made deputy commissioners in the Office of the Commissioner report through Winckler (1"The Tan Sheet" Sept. 3, 2007)